What Is Tissue Engineering?

Tissue engineering is an interdisciplinary field that applies principles of engineering and life sciences to develop biological substitutes that restore, maintain, or improve the function of damaged or diseased tissues and organs. It integrates cell biology, biomaterials science, biochemistry, and mechanical engineering to construct living tissue constructs outside the body, which can then be implanted or used to guide repair in vivo. The field emerged as a distinct discipline in the 1980s and gained formal definition through foundational work by researchers including Robert Langer and Joseph Vacanti, who outlined the strategy of seeding cells onto degradable scaffold frameworks to regenerate functional tissue.

Tissue engineering draws on biological materials science, surface chemistry, and manufacturing engineering to produce constructs that must satisfy competing requirements: mechanical properties that match native tissue, degradation kinetics that align with tissue remodeling, and surface chemistry that promotes cell adhesion and proliferation without triggering adverse immune responses.

Biomaterials and Scaffolds

Scaffolds are three-dimensional structural frameworks that provide a template for cell attachment, growth, and extracellular matrix deposition. Effective scaffold design requires sufficient porosity and interconnected pore architecture to allow nutrient transport and vascularization while maintaining mechanical integrity. Scaffold materials fall into two broad categories: natural polymers such as collagen, fibrin, alginate, and chitosan, which offer inherent biocompatibility; and synthetic polymers such as poly(lactic-co-glycolic acid) (PLGA), polycaprolactone (PCL), and polyethylene glycol (PEG), which allow precise control over degradation rate and mechanical stiffness. NIH-indexed research on biomaterials for tissue engineering describes design principles for bone and cartilage scaffolds, noting the importance of matching scaffold modulus to the target tissue to prevent stress shielding. Surface modification techniques including colloidal lithography, which uses self-assembled nanoparticle arrays to pattern substrate topography at sub-micron scales, and diamond-like carbon coatings, which provide hard, chemically inert biocompatible surfaces, extend the range of scaffold surface properties available to engineers.

Cell Sources and Bioreactor Culture

The cellular component of a tissue-engineered construct is as important as the scaffold. Autologous cells, harvested from the patient, carry no immunological rejection risk but may be limited in quantity or quality. Allogeneic cells from donor tissue and pluripotent stem cells, including induced pluripotent stem cells (iPSCs), address this limitation but introduce considerations of immune modulation and differentiation control. Bioreactors provide the dynamic culture environment needed to scale up cell expansion and drive cell differentiation toward the target tissue phenotype. Spinner flask, rotating wall vessel, and perfusion bioreactor designs each impose distinct fluid shear stress and mass transport conditions. The Springer Nature review on biomaterials and scaffolds for tissue engineering and regenerative medicine covers how bioreactor-conditioned constructs show improved mechanical properties and cell alignment relative to static culture, particularly for cardiovascular and musculoskeletal tissues.

Vascularization and Integration

A persistent challenge in tissue engineering is the creation of functional vasculature within thick constructs. Without an internal microvascular network, cells deeper than approximately 200 micrometers from the surface face oxygen and nutrient limitations that compromise viability. Strategies include co-culture with endothelial cells that self-assemble into capillary-like networks, pre-vascularization in vivo by subcutaneous implantation before transfer to the target site, and bioprinting of channel geometries that guide vascular ingrowth. Research on biomaterial scaffolding in tissue engineering from PMC characterizes the interplay between scaffold pore size and vascular invasion, establishing design windows for bone tissue engineering applications.

Applications

Tissue engineering has applications in a range of fields, including:

• Orthopedic and dental repair using bone and cartilage substitute constructs
• Cardiovascular surgery, including heart valve and vascular graft replacement
• Skin grafts for burn wound coverage and chronic wound management
• Drug testing and disease modeling using in vitro organ-on-chip platforms
• Corneal and tracheal reconstruction in reconstructive and transplant surgery